UPDATE: Needham On Veracyte Price Target Raise Post-Earnings: Firm Highlights Organic Revenue Growth To 77% From 5.7% Q/Q Given Strength From Afirma & Decipher Prostate; Sees Co. 'Positioned To Become One Of The Leaders In Cancer Diagnostics'